About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Higher The Dengue Infection Antibodies, Higher The Protection Against Zika

by Rishika Gupta on February 8, 2019 at 11:06 PM
Font : A-A+

 Higher The Dengue Infection Antibodies, Higher The Protection Against Zika

Antibodies created during a previous dengue infection could lower that person's risk of getting Zika virus, finds a new study. The results of this study are published in the journal of Science.

The higher a person's immunity to dengue virus, the lower their risk of Zika infection, an international team of scientists led by the University of Pittsburgh Graduate School of Public Health, Yale School of Public Health and University of Florida report today in the journal Science.

Advertisement


The study - which followed nearly 1,500 people living in a poor neighborhood at the heart of the 2015 Zika outbreak in Brazil - also provides evidence that Brazil's Zika epidemic has largely petered out because enough people acquired immunity to reduce the efficiency of transmission.

"Take that with a grain of salt, though," said co-senior author Ernesto T.A. Marques, M.D., Ph.D., associate professor in Pitt Public Health's Department of Infectious Diseases and Microbiology and public health researcher at Fundação Oswaldo Cruz in Brazil. "Our study was in a very small urban area, and it is likely that in other parts of Brazil, even different neighborhoods within the same city, people are still susceptible to Zika infection."
Advertisement

The discovery relied on tests for dengue and Zika developed by Marques and his team and patented by Pitt. Marques is scientific director of Cura Zika, an international alliance to spur research into Zika, microcephaly and other congenital conditions it causes in babies.

The research team tapped into a long-running study of the health of people living in urban slums in Salvador, a city in northeast Brazil, led by co-senior author Albert Ko, M.D., chair of epidemiology at the Yale School of Public Health. Study participants gave multiple blood samples before, during and after the Zika epidemic. Samples collected in October 2014 and March 2015 were almost entirely negative for Zika, but by October 2015, 63 percent showed evidence of Zika infection.

Before the Zika outbreak, a subset of 642 participants also had been tested for previous dengue infection, and 86 percent were positive. Specifically, the test assessed the level of antibodies the participants had in their blood against dengue. The team found that each doubling of dengue antibody levels corresponded to a 9 percent reduction in risk of Zika.

"This means that there are some cross-protective antibodies that dengue provides against Zika," said Marques. "Future study may be warranted to assess whether the new dengue vaccines could be useful in preventing Zika infection."

Paradoxically, computational models by co-senior author Derek A.T. Cummings, Ph.D., professor of biology at the University of Florida, revealed that participants who had a very recent dengue infection were more susceptible to Zika.

The scientists suspect several possible explanations: It could be that protective antibodies haven't developed yet or there's something about these people's immune systems that increase their risk of contracting Zika. And the mosquitoes that transmit dengue also transmit Zika, so a recent dengue infection could mean they are in a place where Zika transmission is active as well.

An additional study also is needed to determine how these findings could prove useful to clinicians, Marques said.

Developing reliable, commercially available tests for women of child-bearing age to assess their previous dengue and Zika exposure is of immediate concern, along with evaluating recommendations, so clinicians know what to do with that information, noted Marques. Testing could help clinicians determine whether vaccinating women against dengue could help protect them from Zika during pregnancy. It also would give a baseline, so obstetricians would know how to closely monitor a pregnant woman's fetus for microcephaly, based on her susceptibility to Zika.

Ongoing studies also are following babies born to women who contracted Zika during pregnancy to assess the effect of the mother's immunity to dengue on the degree of Zika-related congenital conditions in the babies.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
First Dose of COVID-19 Vaccines May Improve Mental Health
Printed Temperature Sensors help with Continuous Temperature Monitoring
Health Benefits of Giloy
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Dengue Fever Dengue / Dengue Hemorrhagic Fever Mosquito Diseases Dengue and Homeopathy Chikungunya and Homeopathy Chikungunya Dengue Flu Top 15 Do´s and Don´ts for Preventing and Managing Dengue Fever Dengue Vaccine 

Recommended Reading
Severity of Dengue can be Predicted Through 20 Genes
Researchers have identified 20 genes that can predict an individual's likelihood of developing a ......
New Insights Into The Zika And Dengue Virus Infection Mechanism Found
Dengue and Zika virus infection has been found to up against a human and mosquito immune defense ......
More Than 800 People Diagnosed with Dengue in Delhi During November
Delhi reports more than 800 cases of Dengue during November, according to a municipal report....
New 280 Cases of Dengue Reported in October in New Delhi
Around 280 fresh cases of dengue was reported in New Delhi by the end of October, compared to 290 .....
Chikungunya
Chikungunya is a viral disease spread by mosquito bites; it causes fever, severe joint pain and rash...
Dengue
Dengue is a tropical disease caused by mosquitoes carrying the dengue virus. Symptoms include fever,...
Dengue / Dengue Hemorrhagic Fever
Encyclopedia section of medindia gives general information about Dengue and Dengue Hemorrhagic ......
Dengue Vaccine
Several dengue vaccines are under development. Dengvaxia, Sanofi’s live-attenuated tetravalent dengu...
Mosquito Diseases
Mosquito-borne diseases, like malaria, filaria, dengue, etc are common in places conducive of mosqu...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use